David Tuller returns to discuss his efforts to expose the methodological and ethical problems with the PACE trial for ME/CFS.
David Tuller returns to discuss the continuing saga of the UK’s PACE trial for chronic fatigue syndrome, including the accusation that he is engaging in libelous blogging.
Vincent speaks with David Tuller about flaws in the U.K’s $8 million PACE trial for chronic fatigue syndrome, and efforts to have the trial data released.
The TWiVonauts review how the weather affects West Nile virus disease in the US, benefit of B cell depletion for ME/CFS patients, and an autoimmune reaction induced by influenza virus vaccine that leads to narcolepsy.
The TWiV team discusses the possible association of the respiratory pathogen enterovirus D68 with neurological disease.
TWiV 136: Exit XMRV
- June 5, 2011
- Tagged as: CFS, Chronic Fatigue Syndrome, gammaretrovirus, mecfs, retrovirus, viral, virology, virus, XMRV
Retrovirologist Stephen Goff joins Vincent, Rich, and Alan for a discussion of recent papers on the retrovirus XMRV and its association with chronic fatigue syndrome and prostate cancer.
Vincent, Alan, and Rich talk about XMRV integration sites in prostate tumor DNA, the decline effect and scientific method, and the first virus of Caenorhabditis nematodes.
Vincent and journalist David Tuller converse about the state of science reporting by the press.
Vincent and Alan review recent findings on the association of the retrovirus XMRV with ME/CFS, reassortment of 2009 pandemic H1N1 influenza virus in swine, and where influenza viruses travel in the off-season.